For: | Si XY, Merlin D, Xiao B. Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease. World J Gastroenterol 2016; 22(34): 7718-7726 [PMID: 27678353 DOI: 10.3748/wjg.v22.i34.7718] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i34/7718.htm |
Number | Citing Articles |
1 |
Bojan Čalija, Jela Milić. Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches. Arhiv za farmaciju 2017; 67(3): 124 doi: 10.5937/arhfarm1702124C
|
2 |
Michal Caspi, Amnon Wittenstein, Michal Kazelnik, Yarden Shor-Nareznoy, Rina Rosin-Arbesfeld. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Advanced Drug Delivery Reviews 2021; 169: 118 doi: 10.1016/j.addr.2020.12.010
|
3 |
Mohammed Tayeb Oucif Khaled, Abdelmalekd Zaater, Ilham Ben Amor, Soumeia Zeghoud, Asma Ben Amor, Hadia Hemmami, Ali Alnazza Alhamad. Drug delivery methods based on nanotechnology for the treatment of eye diseases. Annals of Medicine & Surgery 2023; 85(12): 6029 doi: 10.1097/MS9.0000000000001399
|
4 |
Amandeep Singh, Kirandeep Kaur, Uttam Kumar Mandal, Raj Kumar Narang. Nanoparticles as Budding Trends in Colon Drug Delivery for the Management of Ulcerative Colitis. Current Nanomedicine 2020; 10(3): 225 doi: 10.2174/2468187310999200621200615
|
5 |
Chandrakantsing Pardeshi, Ganesh Shevalkar, Mahesh Umbarkar, Dipak Bari, Kamalesh Mali, Sameer Lakade, Mónica García. Advanced Drug Delivery Systems for Colonic Disorders. 2024; : 345 doi: 10.1016/B978-0-443-14044-0.00014-4
|
6 |
Dinakar Swastha, Nambolan Varsha, Suresh Aravind, Kavassery Balasubramanian Samyuktha, Muruganandam Mohaneswari Yokesh, Akshad Balde, Bakthavatchalam Loganathan Ayilya, Soottawat Benjakul, Se-Kwon Kim, Rasool Abdul Nazeer. Alginate-based drug carrier systems to target inflammatory bowel disease: A review. International Journal of Biological Macromolecules 2023; 244: 125472 doi: 10.1016/j.ijbiomac.2023.125472
|
7 |
Prasad Minakshi, Rajesh Kumar, Mayukh Ghosh, Basanti Brar, Manju Barnela, Preeti Lakhani. Application of Polymeric Nano-Materials in Management of Inflammatory Bowel Disease. Current Topics in Medicinal Chemistry 2020; 20(11): 982 doi: 10.2174/1568026620666200320113322
|
8 |
Vijay Kumar Singh, Veena Singh, Vishal Tyagi. Colon Cancer Diagnosis and Therapy. 2021; : 303 doi: 10.1007/978-3-030-64668-4_14
|
9 |
Yanhong Wu, Shangyong Li, Mengfei Jin, Dandan Li, Zihan Zhou, Haiqing Hou, Yantao Han. Preparation of MSZ Hydrogel and Its Treatment of Colitis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.706401
|
10 |
Amusa S. Adebayo, Kafilat Agbaje, Simeon K. Adesina, Oluwabukunmi Olajubutu. Colorectal Cancer: Disease Process, Current Treatment Options, and Future Perspectives. Pharmaceutics 2023; 15(11): 2620 doi: 10.3390/pharmaceutics15112620
|
11 |
M. Khotimchenko. Pectin polymers for colon-targeted antitumor drug delivery. International Journal of Biological Macromolecules 2020; 158: 1110 doi: 10.1016/j.ijbiomac.2020.05.002
|
12 |
Yunyue Zhang, Maya Thanou, Driton Vllasaliu. Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease. European Journal of Pharmaceutics and Biopharmaceutics 2020; 155: 128 doi: 10.1016/j.ejpb.2020.08.017
|
13 |
Mahmood Barani, Mahwash Mukhtar, Abbas Rahdar, Saman Sargazi, Sadanand Pandey, Misook Kang. Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Human Osteosarcoma. Biosensors 2021; 11(2): 55 doi: 10.3390/bios11020055
|
14 |
Abinaya Shanmugavadivu, Sundaravadhanan Lekhavadhani, P J Miranda, Nagarajan Selvamurugan. Current approaches in tissue engineering-based nanotherapeutics for osteosarcoma treatment. Biomedical Materials 2024; 19(2): 022003 doi: 10.1088/1748-605X/ad270b
|
15 |
ROZHAN ARIF MUHAMMED, SAYA MOHAMMED, SHARAD VISHT, ALI OMAR YASSEN. A REVIEW ON DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM. International Journal of Applied Pharmaceutics 2024; : 12 doi: 10.22159/ijap.2024v16i2.49293
|
16 |
C. Sarath Chandran, Krishnameera Sajayan, Jeeva C. Soman, P.K. Anjana, K.K. Swathy, A.S. Vishnu, Shijina Kappally. Advanced Drug Delivery Systems for Colonic Disorders. 2024; : 207 doi: 10.1016/B978-0-443-14044-0.00001-6
|
17 |
Mengchi Sun, Weiyue Ban, Hao Ling, Xiang Yu, Zhonggui He, Qikun Jiang, Jin Sun. Emerging nanomedicine and prodrug delivery strategies for the treatment of inflammatory bowel disease. Chinese Chemical Letters 2022; 33(10): 4449 doi: 10.1016/j.cclet.2022.03.061
|
18 |
Rania E. El-Desoky Mohamady, Sania K. Elwia, Sahar M. Abo El Wafa, Mona Ataya Mohamed. Effect of mesenchymal stem cells derived exosomes and green tea polyphenols on acetic acid induced ulcerative colitis in adult male albino rats. Ultrastructural Pathology 2022; 46(2): 147 doi: 10.1080/01913123.2022.2039825
|
19 |
Shuangquan Gou, Yamei Huang, Junsik Sung, Bo Xiao, Didier Merlin. Silk fibroin-based Nanotherapeutics: Application in the Treatment of Colonic Diseases. Nanomedicine 2019; 14(17): 2373 doi: 10.2217/nnm-2019-0058
|
20 |
Bo Xiao, Qiubing Chen, Zhan Zhang, Lixin Wang, Yuejun Kang, Timothy Denning, Didier Merlin. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis. Journal of Controlled Release 2018; 287: 235 doi: 10.1016/j.jconrel.2018.08.021
|
21 |
Rabia Arshad, Mahmood Barani, Abbas Rahdar, Saman Sargazi, Magali Cucchiarini, Sadanand Pandey, Misook Kang. Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma. Biosensors 2021; 11(4): 97 doi: 10.3390/bios11040097
|
22 |
Mahmood Barani, Abbas Rahdar, Saman Sargazi, Mohammad Sadegh Amiri, Preetam Kumar Sharma, Nikhil Bhalla. Nanotechnology for inflammatory bowel disease management: Detection, imaging and treatment. Sensing and Bio-Sensing Research 2021; 32: 100417 doi: 10.1016/j.sbsr.2021.100417
|
23 |
Kristina Zlatina, Sebastian P. Galuska. The N-glycans of lactoferrin: more than just a sweet decoration. Biochemistry and Cell Biology 2021; 99(1): 117 doi: 10.1139/bcb-2020-0106
|
24 |
Mehrdad Afarid, Shirin Mahmoodi, Roghayyeh Baghban. Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01567-7
|
25 |
Rajesh Singh Pawar, Shweta Kumar, Sulakshana Pawar. Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy. 2024; : 303 doi: 10.1016/B978-0-323-95303-0.00001-0
|
26 |
Tivadar Feczkó. Polymeric nanotherapeutics acting at special regions of body. Journal of Drug Delivery Science and Technology 2021; 64: 102597 doi: 10.1016/j.jddst.2021.102597
|
27 |
Muhammad Naeem, Uzma Azeem Awan, Fazli Subhan, Jiafu Cao, Shwe Phyu Hlaing, Juho Lee, Eunok Im, Yunjin Jung, Jin-Wook Yoo. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Archives of Pharmacal Research 2020; 43(1): 153 doi: 10.1007/s12272-020-01219-0
|
28 |
Marcel Vetter, Markus F. Neurath. Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges. Therapeutic Advances in Gastroenterology 2017; 10(10): 773 doi: 10.1177/1756283X17727388
|
29 |
Lauren J. Mohan, Jacqueline S. Daly, Barbara M. Ryan, Zebunnissa Ramtoola. The future of nanomedicine in optimising the treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2019; 54(1): 18 doi: 10.1080/00365521.2018.1563805
|
30 |
Lauren J. Mohan, Lauren McDonald, Jacqueline S. Daly, Zebunnissa Ramtoola. Optimising PLGA-PEG Nanoparticle Size and Distribution for Enhanced Drug Targeting to the Inflamed Intestinal Barrier. Pharmaceutics 2020; 12(11): 1114 doi: 10.3390/pharmaceutics12111114
|
31 |
Muhammad Bilal, Leonardo Vieira Nunes, Marco Thúlio Saviatto Duarte, Luiz Fernando Romanholo Ferreira, Renato Nery Soriano, Hafiz M. N. Iqbal. Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory Bowel Disease. Marine Drugs 2021; 19(4): 196 doi: 10.3390/md19040196
|
32 |
Rahul Mittal, Amit P. Patel, Vasanti M. Jhaveri, Sae-In S. Kay, Luca H. Debs, James M. Parrish, Debbie R. Pan, Desiree Nguyen, Jeenu Mittal, Rahul Dev Jayant. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders. Expert Opinion on Drug Delivery 2018; 15(3): 301 doi: 10.1080/17425247.2018.1420055
|
33 |
Yilin Guo, Shiyu Zong, Yiqiong Pu, Benliang Xu, Tong Zhang, Bing Wang. Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease. Molecules 2018; 23(7): 1622 doi: 10.3390/molecules23071622
|
34 |
Yamei Huang, Brandon S. B. Canup, Shuangquan Gou, Nanxi Chen, Fangyin Dai, Bo Xiao, Changming Li. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues. Journal of Materials Chemistry B 2021; 9(6): 1604 doi: 10.1039/D0TB02092C
|
35 |
Sang Hoon Lee, Rajiv Bajracharya, Jeong Youn Min, Ji-Won Han, Byeong Ju Park, Hyo-Kyung Han. Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements. Pharmaceutics 2020; 12(1): 68 doi: 10.3390/pharmaceutics12010068
|
36 |
Fanny Giron, Anna Pastó, Ennio Tasciotti, Bincy P Abraham. Nanotechnology in the Treatment of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019; 25(12): 1871 doi: 10.1093/ibd/izz205
|